22 November 2017
News and Views
Links and Services
There is a lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in HCV-related cirrhosis, reports August‘s American Journal of Gastroenterology.
The likelihood of developing hepatocellular carcinoma in patients coinfected with both Hepatitis
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors